Insulin Resistance And End Stage Renal Disease: The Role Of Retinol Binding Protein 4

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00910130

Enrollment

Registered

2009-05-29

Start date

2008-07-31

Completion date

Unknown

Last updated

2009-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes, End Stage Renal Disease, Insulin Resistance

Keywords

Retinol Binding Protein 4, Insulin Resistance, Diabetes, End Stage Renal Disease, Dialysis, Nutrition

Brief summary

The purpose of this study is to determine whether Retinol binding protein 4 has a role in insulin resistance development in patients suffering from end stage renal disease on hemodialysis.

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

18 Years to 70 Years

Healthy volunteers

Yes

Inclusion criteria

* Hemodialysis for End Stage Renal Disease group * Normal Renal Function for Control group

Exclusion criteria

* Diabetes * Malnutrition * Malignancy * Acute Infection * Chronic Active Infection

Countries

Italy

Contacts

Primary ContactGiovanni Piotti, MD

gpiotti@yahoo.it+390382502590

Backup ContactTeresa Rampino, MD

t.rampino@smatteo.pv.it+390382503896

Outcome results